Microbot Medical Inc.

Equities

MBOT

US59503A2042

Biotechnology & Medical Research

Market Closed - Nasdaq 04:00:00 2024-04-23 pm EDT 5-day change 1st Jan Change
0.8799 USD -0.86% Intraday chart for Microbot Medical Inc. -2.23% -46.35%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
HC Wainwright Adjusts Microbot Medical's Price Target to $7 From $8, Keeps Buy Rating MT
Microbot Medical Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Microbot Medical Submits US FDA Application to Start Human Clinical Trial for Robotic Surgical System MT
Microbot Medical Submits an IDE Application to Gain FDA Approval to Commence Its Pivotal Clinical Trial in the US CI
Microbot Medical Expands US Clinical Infrastructure in Support of the Upcoming IDE Submission to Commence its First in Human Clinical Study CI
Sector Update: Health Care Stocks Ease Friday Afternoon MT
Microbot Medical to Exercise Outstanding Preferred Investment Options for $2.7 Million MT
Sector Update: Health Care Stocks Rise in Late Afternoon MT
Microbot Medical Says GLP Preclinical Study of Liberty Endovascular Robotic Surgical System Met Objectives; Shares Rise MT
Sector Update: Health Care Stocks Advance Thursday Afternoon MT
Microbot Medical Announces Positive Results of Its GLP Pivotal Pre-Clinical Study Where All Study Objectives Met CI
Microbot Medical and Corewell Health Forge Collaboration to Establish the LIBERTY Endovascular Robotic Surgical System for Telerobotic CI
Microbot Medical Announces the Successful Completion of its GLP Pivotal Pre-Clinical Study CI
Microbot Medical Inc. Announces Executive Changes CI
Microbot Medical Files $75 Million Shelf MT
Microbot Medical Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Microbot Medical Inc. Successfully Completed Integral Part of the Verification and Validation Process CI
Sector Update: Health Care Stocks Mixed Late Wednesday Afternoon MT
Sector Update: Health Care Stocks Lower in Afternoon Trading MT
Microbot Medical Gets Registered Trademark From US Patent and Trademark Office MT
Microbot Medical Inc. Approves Ratification of Brightman Almagor Zohar & Co. as Independent Registered Public Accounting Firm CI
Microbot Medical Reveals Successful Short Term Follow Up Outcomes from Its Pivotal Pre-Clinical Study CI
Microbot Medical Says Court Dismisses Counterclaim Against Company in Short-Swing Lawsuit MT
Microbot Medical Inc. Announces Successful Initial Outcomes from its Pivotal Pre-Clinical Study with the LIBERTY Robotic Surgical System CI
Microbot Medical Inc. Announces the Resignation of Eyal Morag as Chief Medical Officer, Effective November 29, 2023 CI
Chart Microbot Medical Inc.
More charts
Microbot Medical Inc. is a pre-clinical medical device company. The Company is specializing in the research, design and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. It is primarily focused on leveraging its robotic technologies with surgical robotics to improve surgical outcomes for patients. Its technological platforms include LIBERTY and NovaCross. Using its LIBERTY Endovascular Robotic Surgical System, it is developing a fully disposable robot for various endovascular interventional procedures. The LIBERTY Endovascular Robotic Surgical System is designed to maneuver guidewires and over-the-wire devices (such as microcatheters) within the body’s vasculature. It eliminates the need for capital equipment requiring dedicated Cath-lab rooms as well as dedicated staff. LIBERTY Endovascular Robotic Surgical System addresses the needs of interventional cardiology, interventional radiology and interventional neuroradiology markets.
More about the company
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
0.8875 USD
Average target price
7 USD
Spread / Average Target
+688.73%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. MBOT Stock
  4. News Microbot Medical Inc.
  5. Microbot Medical Says It Has Received Design Patent Grant in Europe for Liberty Robotic System